AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24695091
Drug: Rivaroxaban 10
RxNorm normalized name: rivaroxaban 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 10 mg/day for 14 days
Trial: 7581968
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human growth hormone (rhGH) replacement therapy for 6 months
Trial: 31607143
Drug: Intensive treatment
RxNorm normalized name: Head & Shoulders Intensive Treatment
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive treatment (24-hour mean systolic BP ≤130 mm Hg)
Trial: 18972429
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) chemoradiation
Trial: 28510491
Drug: FP pMDI
RxNorm normalized name: Coagulation Factor IX (Recombinant), Albumin Fusion Protein (rIX-FP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FP pMDI (Flixotide®) 100 μg b.i.d. with Volumatic® spacer
Trial: 11813931
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg BID (IR tablets)
Trial: 9217822
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of betamethasone-17-valerate (once a day) and tretinoin (once a day)
Trial: 23716765
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg
Trial: 1386976
Drug: Ondansetron 12
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron 12 mg
Trial: 12069102
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of Q10 (maximum daily dose recommended)
Trial: 12069102
Drug: Q10 with
RxNorm normalized name: Coenzyme Q10/Red Yeast Rice 60 MG-600 MG Oral Capsule, Liquid Filled [COQ10 WITH RED YEAST RICE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Q10 with minor vitamin E dose
Trial: 7481863
Drug: Paclitaxel plus
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel plus carboplatin (175 mg/m2 in a 3-hour infusion)
Trial: 21762358
Drug: Azilsartan medoxomil
RxNorm normalized name: Azilsartan Medoxomil
DrugBank: Azilsartan medoxomil (DB08822)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azilsartan medoxomil 40 mg and 80 mg
Trial: 19347979
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral carboxyaminoimidazole
Trial: 21425620
Drug: Low power
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low power laser (LPL) treatment, frequency of 73 Hz, 10 minutes per treatment, total dose 15 J.
Trial: 30600526
Drug: IV-only multimodal
RxNorm normalized name: CALCIUM 0.8 ORAL TABLET [OnlyCal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV-only multimodal analgesics (control group)
Trial: 3071032
Drug: diclofenac 50
RxNorm normalized name: DICLOFENAC 50MG/MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac 50 mg plus B vitamins (B1, B6, B12)
Trial: 31515667
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg abiraterone acetate taken with a continental breakfast (CB)
Trial: 21389855
Drug: Vitamin B6
RxNorm normalized name: vitamin B6
DrugBank: Pyridoxine (DB00165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B6 (40 mg)
Trial: 19794266
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg once daily for 1 week, amoxicillin 1g b.i.d, omeprazole 20 mg b.i.d, bismuth 240 mg b.i.d for 2 weeks (AAO-B group)
Trial: 15906123
Drug: Alvimopan 6
RxNorm normalized name: Alvimopan
DrugBank: Alvimopan (DB06274)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alvimopan 6 mg
Trial: 8423882
Drug: Botulinum-A toxin
RxNorm normalized name: Botulinum A neurotoxin
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: Botulinum-A toxin (BTX-A) injections
Trial: 10989320
Drug: 17-beta estradiol
RxNorm normalized name: 17-beta estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17-beta estradiol (E) infusion (20 ng/min)
Trial: 10692926
Drug: Low-dose intravenous
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intravenous infusion of midazolam (0.2 mg/ml of normal saline at a rate of 1 mg/h)
Trial: 15849749
Drug: Education and
RxNorm normalized name: zinc pyrithione Medicated Shampoo [Free and Clear]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education and 800 ml free broad spectrum sunscreens with SPF 25 provided yearly
Trial: 12351466
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein 30 g/day, isoflavones 132 mg/day
Trial: 23548250
Drug: Guided internet-delivered
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided internet-delivered acceptance and commitment therapy (ACT)
Trial: 26420261
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of GA and IS samples
Trial: 23621675
Drug: Acetaminophen and
RxNorm normalized name: Acetaminophen and Aspirin Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen and ibuprofen
Trial: 23621675
Drug: Extended-release diclofenac
RxNorm normalized name: diclofenac Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release diclofenac
Trial: 9003265
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin
Trial: 21712706
Drug: Nonfractionated (NF)
RxNorm normalized name: NFS-02
DrugBank: NFS-02 (DB18422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonfractionated (NF) dose group: paclitaxel (200 mg/m(2)) and carboplatin (AUC=6) on day 1
Trial: 21527231
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups received treatment for constipation and recurrent urinary tract infections (UTIs)
Trial: 18384519
Drug: 24-week treatment
RxNorm normalized name: Weeks and Leo Complete Lice Treatment KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-week treatment regimen of peginterferon and ribavirin
Trial: 10896845
Drug: Free nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Free nicotine patches plus proactive telephone peer support
Trial: 10896845
Drug: Free nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Free nicotine patches only
Trial: 7609499
Drug: sublingual lacidipine
RxNorm normalized name: LACIDIPINE
DrugBank: Lacidipine (DB09236)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual lacidipine 4 mg
Trial: 8314271
Drug: sublingual nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sublingual nifedipine 10 mg
Trial: 3280158
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Diltiazem and Nifedipine)
Trial: 2899588
Drug: Cefuroxime 750
RxNorm normalized name: cefuroxime 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime 750 mg and piperacillin 4 g (3 doses)
Trial: 25332468
Drug: Control essential
RxNorm normalized name: Eucalyptus essential oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control essential amino acids (1.85 g of Leu)
Trial: 30833368
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy
Trial: 12109823
Drug: Cisplatin-based chemotherapy
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin-based chemotherapy plus radiotherapy
Trial: 29901296
Drug: -blocker Fokusin
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: -blocker Fokusin 0.4 mg once a day
Trial: 10518081
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone treatment (4 IU/m(2)/d, 6 IU/m(2)/d, 8 IU/m(2)/d)
Trial: 19776136
Drug: Cocoa powder
RxNorm normalized name: Cocoa powder
DrugBank: Cocoa (DB10977)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocoa powder with 500 mL skim milk/d (C+M)
Trial: 17305650
Drug: Both aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both aspirin and antioxidant vitamins
Trial: 10912607
Drug: Intensive physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive physical therapy
Trial: 28164396
Drug: 5α-reductase inhibitors
RxNorm normalized name: Fibrinolysis inhibitor
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5α-reductase inhibitors (5-ARIs)
Trial: 31879231
Drug: Endovenous treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovenous treatment with lysis and stenting
Trial: 17391164
Drug: Topiramate 96
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate 96 mg/day
Trial: 17391164
Drug: Topiramate 192
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate 192 mg/day
Trial: 19451404
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg single dose
Trial: 9422303
Drug: Epidural anaesthesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural anaesthesia with mepivacaine 20 mg/ml and epinephrine 5 microg/ml, 15‐20 ml (Group E)
Trial: 1747644
Drug: Bismuth subcitrate
RxNorm normalized name: BISMUTH SUBCITRATE
DrugBank: Bismuth subcitrate potassium (DB09275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bismuth subcitrate 120 mg four times a day for four weeks, metronidazole 400 mg three times a day for one week, plus amoxycillin 500 mg three times a day for the first week
Trial: 26864127
Drug: D2-biofortified bread
RxNorm normalized name: vitamin D2
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: D2-biofortified bread (25 µg D2/d)
Trial: 15098799
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice (240 ml, regular-strength)
Trial: 17662090
Drug: L-Citrulline
RxNorm normalized name: L-citrulline
DrugBank: Citrulline (DB00155)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-Citrulline
Trial: 3319859
Drug: Conventional insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional insulin treatment (CI)
Trial: 2873010
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg flunitrazepam
Trial: 11717622
Drug: Patients without
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients without beta(2)-adrenergic receptor agonists (group B)
Trial: 9137794
Drug: Standard-dose cytarabine
RxNorm normalized name: Cytarabine
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Standard-dose cytarabine (SDAC: 100 mg/sqm 24 hours infusion over seven days)
Trial: 11977509
Drug: Shu Feng
RxNorm normalized name: Feng Mi
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shu Feng Huo Luo Pian, 2 pills, p.o., bid, supplemented with calcium Caltrate D 0.6 g, p.o., qd for 2 courses (2 weeks each)
Trial: 22874843
Drug: Intravenous sodium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous sodium load
Trial: 3931136
Drug: methylclonazepam 1
RxNorm normalized name: N-Methyllorazepam
DrugBank: Lormetazepam (DB13872)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: methylclonazepam 1 mg
Trial: 17110897
Drug: Continuous intraperitoneal
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intraperitoneal insulin infusion (CIpii)
Trial: 29231544
Drug: Oral lactulose
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral lactulose (3 times a day for 8 weeks)
Trial: 23355041
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of gemcitabine and S‐1 (gemcitabine 1,000 mg/m(2) on days 1 and 15 and S‐1 40 mg/m(2) b.i.d. on days 1‐14, repeated every 4 weeks)
Trial: 7076116
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of CDCA and UDCA
Trial: 7076116
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg per kg per day of ursodeoxycholic acid (UDCA)
Trial: 28325124
Drug: Obstetric gel
RxNorm normalized name: chlorhexidine gluconate Topical Cream [Hibitane Obstetric]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Obstetric gel
Trial: 9048267
Drug: Converting enzyme
RxNorm normalized name: Prohormone converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Converting enzyme inhibitors
Trial: 23507709
Drug: Low-dose rosuvastatin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose rosuvastatin (2.5 mg/day)
Trial: 3181102
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid 60 mg
Trial: 10480041
Drug: Guided self-hypnotic
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Guided self-hypnotic relaxation
Trial: 1461786
Drug: Oral amoxicillin
RxNorm normalized name: amoxicillin Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral amoxicillin (40 mg/Kg/dose for 4 days)
Trial: 1461786
Drug: Intravenous amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous amoxicillin (40 mg/Kg/dose for 4 days)
Trial: 10973651
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (goserelin, 3.6 mg every 4 weeks) plus oral placebo
Trial: 10973651
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist (goserelin, 3.6 mg every 4 weeks) plus oral continuous combined estradiol-norethisterone acetate add-back therapy daily for 24 weeks
Trial: 21319897
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) intervention, 8-week group during pregnancy and 3 individual booster sessions postpartum
Trial: 25912697
Drug: Serelaxin 10
RxNorm normalized name: serelaxin
DrugBank: Serelaxin (DB05794)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serelaxin 10 µg·kg(‐1)·day(‐1)
Trial: 17962502
Drug: 12-minute visit
RxNorm normalized name: TAGETES MINUTA FLOWER OIL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-minute visit from a volunteer with a therapy dog
Trial: 19343272
Drug: Alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg once-weekly
Trial: 2007377
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg aspirin daily (group 1)
Trial: 28524257
Drug: 30-week oral
RxNorm normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: 30-week oral language intervention programme
Trial: 19303145
Drug: Self-administered questionnaire
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered questionnaire (SAQ)
Trial: 8432223
Drug: Acarbose 25
RxNorm normalized name: acarbose 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose 25 mg powdered, 3 times a day with meals
Trial: 9084544
Drug: omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omeprazole 40 mg
Trial: 8836705
Drug: ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidine 300 mg
Trial: 8644481
Drug: famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: famotidine 40 mg
Trial: 19590458
Drug: Black cohosh
RxNorm normalized name: black cohosh
DrugBank: Black cohosh (DB13975)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black cohosh (128 mg)
Trial: 24231627
Drug: Cetuximab plus
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab plus pemetrexed (400 mg/m2 at first dose and 250 mg/m2 weekly thereafter)
Trial: 31768718
Drug: Multidisciplinary intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multidisciplinary intervention for encopresis (MIE); Treatment for constipation, 10-day behavioral intervention utilizing suppositories
Trial: 10371003
Drug: Follow-up questionnaire
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Follow-up questionnaire (1-4 years after treatment)
Trial: 12614088
Drug: Multivitamin and
RxNorm normalized name: Multivitamin and Minerals Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin and mineral supplement among diabetic participants
Trial: 30641815
Drug: Full ozone
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full ozone therapy
Trial: 1607582
Drug: Study drugs
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Study drugs (encainide, flecainide or moricizine)
Trial: 11224578
Drug: High fluoride
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High fluoride ingestion (2.4, 4.6, 5.6, and 13.5 mg/l)
Trial: 16856904
Drug: Metronidazole plus
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole plus amoxicillin (M+A) for 7 days
Trial: 28633702
Drug: Isoniazid preventive
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid preventive therapy (IPT)
Trial: 21087166
Drug: Intravaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal misoprostol (50-μg) plus oxytocin
Trial: 18155284
Drug: Grass allergen
RxNorm normalized name: orchardgrass allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grass allergen tablet immunotherapy (GRAZAX)
Trial: 20122374
Drug: Videoteleconferencing anger
RxNorm normalized name: After banger
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Videoteleconferencing anger management therapy (n = 61)
Trial: 20122374
Drug: In-person anger
RxNorm normalized name: After banger
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: In-person anger management therapy (n = 64)
Trial: 8855675
Drug: roxithromycin 300
RxNorm normalized name: roxithromycin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxithromycin 300 mg once daily
Trial: 6089857
Drug: edrophonium 1
RxNorm normalized name: edrophonium 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: edrophonium 1 mg kg‐1
Trial: 8452166
Drug: Fleroxacin 400
RxNorm normalized name: fleroxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin 400 mg once daily for 7-14 days
Trial: 18594417
Drug: Enoxaparin administration
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin administration
Trial: 10999778
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg calcium daily
Trial: 3048225
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg scopolamine hydrobromide
Trial: 3899624
Drug: Flunarizine at
RxNorm normalized name: flunarizine
DrugBank: Flunarizine (DB04841)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine at doses of 15-20 mg daily
Trial: 25991692
Drug: Calcium dobesilate
RxNorm normalized name: CALCIUM DOBESILATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium dobesilate 500 mg, three times daily for 12 weeks
Trial: 25201463
Drug: Mg + H2 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mg + H2 group
Trial: 20598044
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist (cetrorelix)